Riley Children’s Health standardizing genomic care and use of rGS in NICU

At Riley Children’s Health, specialists are utilizing rapid genome sequencing (rGS) for detecting genetic disease in hospitalized infants in the neonatal intensive care unit (NICU) and changing patient care. Kristen Suhrie, MD, neonatal-perinatal medicine specialist and medical director of perinatal genomics, in collaboration with colleagues in neonatology and genetics, developed a new NICU genetic evaluation algorithm which led to a paradigm shift in current practice across Riley Children’s NICUs.

Watch this webinar to learn how Riley specialists approached standardizing genomic care and rGS in the NICU, and learn more about the results:

• Many different symptoms are seen in the NICU that indicate possible genetic disease
• Many unique genetic diagnoses are found in NICU patients
• Families overwhelming want genomic testing for their babies
• Allows for equitable access to genomic care
• A 50% increase in genetic disease detection
• Shorter lengths of stay in the NICU

At Riley Children’s, the Perinatal Genomics Program offers comprehensive clinical care, education and research for neonatal genetic disease. See how Riley Children’s is leading the way in providing innovative care for critically ill newborns.